Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B.

J Mol Biol

Department of Pharmacology and Toxicology, Cancer Center and Cardiovascular Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. Electronic address:

Published: December 2016

Two isoforms of the small GTPase Rap1, Rap1A and Rap1B, participate in cell adhesion; Rap1A promotes steady state adhesion, while Rap1B regulates dynamic changes in cell adhesion. These events depend on the prenylation of Rap1, which promotes its membrane localization. Here, we identify previously unsuspected differences in the regulation of prenylation of Rap1A versus Rap1B, due in part to their different phosphorylation-dependent interactions with the chaperone protein SmgGDS-607. Previous studies indicate that the activation of Gα protein-coupled receptors (GPCRs) phosphorylates S-179 and S-180 in the polybasic region (PBR) of Rap1B, which inhibits Rap1B binding to SmgGDS-607 and diminishes Rap1B prenylation and membrane localization. In this study, we investigate how phosphorylation in the PBR of multiple small GTPases, including K-Ras4B, RhoA, Rap1A, and Rap1B, affects their binding to SmgGDS, with emphasis on differences between Rap1A and Rap1B. We identify the amino acids in SmgGDS-607 necessary for binding of Rap1A and Rap1B, and present homology models examining the binding between Rap1A or Rap1B and SmgGDS-607. Unlike Rap1B, phosphorylation in the PBR of Rap1A does not detectably inhibit its prenylation or its binding to SmgGDS-607. Activation of GPCRs suppresses Rap1A prenylation, but unlike this effect on Rap1B, the GPCR-mediated suppression of Rap1A prenylation can occur independently of Rap1A phosphorylation and does not detectably diminish Rap1A membrane localization. These data demonstrate unexpected evolutionarily conserved differences in the ability of GPCRs to regulate the prenylation of Rap1B compared to Rap1A.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153279PMC
http://dx.doi.org/10.1016/j.jmb.2016.10.016DOI Listing

Publication Analysis

Top Keywords

rap1a rap1b
24
rap1a
14
rap1b
14
membrane localization
12
prenylation
8
regulation prenylation
8
prenylation rap1a
8
cell adhesion
8
rap1b binding
8
binding smggds-607
8

Similar Publications

Background: Store-operated calcium entry mediated by STIM (stromal interaction molecule)-1-Orai1 (calcium release-activated calcium modulator 1) is essential in endothelial cell (EC) functions, affecting signaling, NFAT (nuclear factor for activated T cells)-induced transcription, and metabolic programs. While the small GTPase Rap1 (Ras-proximate-1) isoforms, including the predominant Rap1B, are known for their role in cadherin-mediated adhesion, EC deletion of Rap1A after birth uniquely disrupts lung endothelial barrier function. Here, we elucidate the specific mechanisms by which Rap1A modulates lung vascular integrity and inflammation.

View Article and Find Full Text PDF

RAP1 proteins belong to the RAS family of small GTPases that operate as molecular switches by cycling between GDP-bound inactive and GTP-bound active states. The C-terminal anchors of RAP1 proteins are known to direct membrane localization, but how these anchors organize RAP1 on the plasma membrane (PM) has not been investigated. Using high-resolution imaging, we show that RAP1A and RAP1B form spatially segregated nanoclusters on the inner leaflet of the PM, with further lateral segregation between GDP-bound and GTP-bound proteins.

View Article and Find Full Text PDF

Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol.

Cell Mol Life Sci

May 2024

Liaoning Technology and Engineering Center for Tumor Immunology and Molecular Theranotics, Collaborative Innovation Center for Age-Related Disease, Life Science Institute of Jinzhou Medical University, Jinzhou, 121001, Liaoning, China.

Vemurafenib has been used as first-line therapy for unresectable or metastatic melanoma with BRAFV600E mutation. However, overall survival is still limited due to treatment resistance after about one year. Therefore, identifying new therapeutic targets for melanoma is crucial for improving clinical outcomes.

View Article and Find Full Text PDF

Vascular permeability is dynamically but tightly controlled by vascular endothelial (VE)-cadherin-mediated endothelial cell-cell junctions to maintain homeostasis. Thus, impairments of VE-cadherin-mediated cell adhesions lead to hyperpermeability, promoting the development and progression of various disease processes. Notably, the lungs are a highly vulnerable organ wherein pulmonary inflammation and infection result in vascular leakage.

View Article and Find Full Text PDF

cAMP-Epac1 signaling is activated in DDAVP-induced endolymphatic hydrops of guinea pigs.

Braz J Otorhinolaryngol

May 2023

Affiliated Hospital of Xuzhou Medical University, Department of Otorhinolaryngology-Head and Neck Surgery, Xuzhou, China; Xuzhou Medical University, Institute of Audiology and Balance Science, Xuzhou, China; Xuzhou Medical University, Artificial Auditory Laboratory of Jiangsu Province, Xuzhou, China. Electronic address:

Article Synopsis
  • The study aimed to investigate the activation of cAMP-Epac1 signaling in guinea pigs with endolymphatic hydrops induced by DDAVP, a synthetic vasopressin.
  • Eighteen guinea pigs were divided into three groups to receive different treatments over 7 or 14 days, and their cochlea tissues were analyzed for specific mRNA and protein expressions using RT-PCR and Western blotting.
  • Results indicated that the DDAVP-treated groups showed significant changes in the expression of Epac1, Epac2, and Rap proteins compared to the control group, suggesting the potential involvement of cAMP-Epac1 signaling in DDAVP-induced endolymphatic hydrops.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!